Protecting Consumer Access to Generic Drugs Act of 2026

Official title: To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.

1. house
3. senate
5. president

Introduced October 22, 2026 by Seth Magaziner · Last progress October 22, 2026